share_log

大幸薬品:2024年第2四半期の決算の要約

Taiko Pharmaceutical: Summary of the Q2 2024 financial statements.

JPX ·  Aug 9 02:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more